Modulation of survivin reverses cardiac and pulmonary remodeling in monocrotaline-induced pulmonary arterial hypertension

被引：0
|
作者：
Ana Filipa Silva, A. F. [1 ]
Ferreira-Pinto, M. J. [1 ]
Justino, J. [2 ]
Nogueira-Ferreira, R. [2 ]
Padrao, A. I. [2 ]
Carneiro, F. [1 ]
Moreira-Goncalves, D. [3 ]
Leite-Moreira, A. F. [1 ]
Henriques-Coelho, T. [1 ]
机构：
[1] Univ Porto, Fac Med, Dept Physiol & Cardiothorac Surg, P-4100 Oporto, Portugal
[2] Univ Aveiro, QOPNA, P-3800 Aveiro, Portugal
[3] Univ Porto, Fac Sport, Res Ctr Phys Act Hlth & Leisure, P-4100 Oporto, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
160
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [21] Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension
    Wei Wang
    Yu-lin Wang
    Xiao-ying Chen
    Yu-tang Li
    Wei Hao
    You-peng Jin
    Bo Han
    Molecular Biology Reports, 2011, 38
  • [22] Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats
    Hongo, M
    Mawatari, E
    Tsutsui, H
    Yazaki, Y
    Kinoshita, O
    Ikeda, U
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S307 - S307
  • [23] Pexidartinib Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
    Nishiura, Kazuto
    Yokokawa, Tetsuro
    Misaka, Tomofumi
    Miura, Shunsuke
    Tomita, Yusuke
    Sato, Akihiko
    Oikawa, Masayoshi
    Sugimoto, Koichi
    Nakazato, Kazuhiko
    Takeishi, Yasuchika
    CIRCULATION, 2023, 148
  • [24] Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
    Tang, Yi
    Tan, Siyuan
    Li, Minqi
    Tang, Yijin
    Xu, Xiaoping
    Zhang, Qinghai
    Fu, Qinghua
    Tang, Mingxiang
    He, Jin
    Zhang, Yi
    Zheng, Zhaofen
    Peng, Jianqiang
    Zhu, Tengteng
    Xie, Wenlin
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [25] Dihydromyricetin prevents monocrotaline-induced pulmonary arterial hypertension in rats
    Li, Qinghai
    Wang, Jun
    Zhu, Xianying
    Zeng, Zhilin
    Wu, Xiaomei
    Xu, Yongjian
    Xie, Jungang
    Yu, Jun
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 96 : 825 - 833
  • [26] Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
    Tong, Yi
    Jiao, Qian
    Liu, Yuanru
    Lv, Jiankun
    Wang, Rui
    Zhu, Lili
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [27] Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats
    Jiang, Wei-Long
    Han, Xiao
    Zhang, Yu-Feng
    Xia, Qing-Qing
    Zhang, Jia-Ming
    Wang, Feng
    RSC ADVANCES, 2019, 9 (01) : 552 - 559
  • [28] Effects of nicorandil on monocrotaline-induced pulmonary arterial hypertension in rats
    Hongo, M
    Mawatari, E
    Sakai, A
    Ruan, Z
    Koizumi, T
    Terasawa, F
    Yazaki, Y
    Kinoshita, O
    Ikeda, U
    Shibamoto, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (04) : 452 - 458
  • [29] Attenuation of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats by Rosuvastatin
    Li, Xiao-Lin
    Guan, Rui-Jin
    Li, Jian-Jun
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (02) : 219 - 226
  • [30] Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
    Huang, Lin
    Li, Huayang
    Huang, Suiqing
    Wang, Shunjun
    Liu, Quan
    Luo, Li
    Gan, Shuangjiao
    Fu, Guangguo
    Zou, PeiYun
    Chen, Guangxian
    Wu, Zhongkai
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345